本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Protagonist Therapeutics Inc

103.73
-1.7100-1.62%
盤後103.730.00000.00%17:17 EDT
成交量:41.78萬
成交額:4,330.34萬
市值:66.19億
市盈率:-50.60
高:104.53
開:103.59
低:102.46
收:105.44
52周最高:107.84
52周最低:41.29
股本:6,380.87萬
流通股本:4,315.48萬
量比:0.52
換手率:0.97%
股息:- -
股息率:- -
每股收益(TTM):-2.0500
每股收益(LYR):-2.0500
淨資產收益率:-20.18%
總資產收益率:-13.99%
市淨率:10.77
市盈率(LYR):-50.60

資料載入中...

2021/05/28

重要事件披露

8-K - Current report
2021/05/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/04

重要事件披露

8-K - Current report
2021/03/10

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/10

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/10

重要事件披露

8-K - Current report
2021/02/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/11

重要事件披露

8-K - Current report
2020/11/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/04

重要事件披露

8-K - Current report
2020/10/02

重要事件披露

8-K/A [Amend] - Current report
2020/09/11

重要事件披露

8-K - Current report